BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| (2->1)-beta-D-fructofuranan {Inulin} - Desulfovibrio |
📓
Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats. PeerJ (PeerJ ) Vol: 6 Issue Pages: e4446 Pub: 2018 Epub: 2018 Mar 1 Authors Zhang Q , Yu H , Xiao X , Hu L , Xin F , Yu X , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Desulfovibrio |
👶
Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut (Gut ) Vol: 66 Issue 11 Pages: 1968-1974 Pub: 2017 Nov Epub: 2017 Feb 17 Authors Vandeputte D , Falony G , Vieira-Silva S , Wang J , Sailer M , Theis S , Verbeke K , Raes J , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Desulfovibrio |
📓
Inulin supplementation prior to mild traumatic brain injury mitigates gut dysbiosis, and brain vascular and white matter deficits in mice. Frontiers in microbiomes (Front Microbiomes ) Vol: 1 Issue Pages: Pub: 2022 Epub: 2022 Nov 30 Authors Yanckello LM , Chang YH , Sun M , Chlipala G , Green SJ , Lei Z , Ericsson AC , Xing X , Hammond TC , Bachstetter AD , Lin AL , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Desulfovibrio |
📓
Dietary Inulin Regulated Gut Microbiota and Improved Neonatal Health in a Pregnant Sow Model. Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 716723 Pub: 2021 Epub: 2021 Aug 9 Authors Li H , Ma L , Zhang L , Liu N , Li Z , Zhang F , Liu X , Ma X , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Desulfovibrio |
📓
Agave Inulin Supplementation Affects the Fecal Microbiota of Healthy Adults Participating in a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. The Journal of nutrition (J Nutr ) Vol: 145 Issue 9 Pages: 2025-32 Pub: 2015 Sep Epub: 2015 Jul 22 Authors Holscher HD , Bauer LL , Gourineni V , Pelkman CL , Fahey GC Jr , Swanson KS , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
